Takotsubo Syndrome: New Treatment Approaches

We are studying whether a combination of adenosine and dipyridamole improves outcomes for patients with Takotsubo Syndrome. Additionally, we’re testing if apixaban can lower the risk of blood clots in these patients.

>2 yearsMonitoring phase (IV)Partially RemoteStandard MedicinesOralInjectionCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Adenosin Life Medical
Adenosin Life Medical is a medicine used in hospitals to quickly stop episodes of very fast heart rhythm and restore a normal heartbeat.
Dipyridamol Alternova
Dipyridamol Alternova is a medicine that helps prevent blood clots and lowers the risk of stroke.
Eliquis
Eliquis is a medicine that helps prevent harmful blood clots and lowers the risk of stroke.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Adenosine
Adenosine is a substance that quickly restores normal heart rhythm during certain types of rapid heartbeats.
Apixaban
Apixaban is a substance that helps prevent harmful blood clots and lowers stroke risk in people with irregular heart rhythm.
Dipyridamole
Dipyridamole is a substance that helps prevent blood clots by stopping platelets from sticking together.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abatixent
Abidalo
Aboxoma

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Aarhus Universitetshospital
Department of Cardiology
Århus, Denmark
Rigshospitalet
Department of Cardiology
Copenhagen, Denmark
Oslo University Hospital HF
Department of Cardiology
Oslo, Norway
Sponsor: Vastra Gotalandsregionen
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.